News

Advisory Committee

Purpose of the Advisory Committee

The Board shall present the Advisory Committee with its action plan developed to serve the goals of the Corporation and shall solicit advice on the types of activities that would be most useful to various stakeholders. The Board can consult the Advisory Committee on strategic options for the Corporation. Every two years, the Advisory Committee will report on its activities at the general meeting.

Membership
The Advisory Committee shall consist of no more than 15  ISBR Members with a broad geographic representation and approximately equal distribution among the three constituencies :

  1. key regulatory agencies and other governmental offices,
  2. respected scientists/individuals representing stakeholders involved in the development of products using the techniques of biotechnology, who come from the biotechnology industry or academia, and elsewhere and 
  3. respected scientists/individuals representing stakeholders involved in environmental biosafety assessments of GMOs, who could come from nongovernmental organizations or academia, and who consider environmental biosafety issues from a scientific perspective.


Advisory Committee members shall be chosen based on their demonstrated expertise and their ability to engage in reasoned, non-confrontational evaluations of the environmental safety of GMOs.

Chair of the Advisory Committee
Sally McCammon (USA)

Additional members of the Advisory Committee

Candidates have to be approved.